Duration antiviral agents. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy15

Cell Line Vero Cells Cells, Cultured HeLa Cells Cell Line, Tumor Liver Capsid CD8-Positive T-Lymphocytes L Cells (Cell Line)CD4-Positive T-Lymphocytes T-Lymphocytes, Cytotoxic HEK293 Cells Fibroblasts Virion Dendritic Cells

Organisms48

Hepacivirus HIV-1 Cytomegalovirus Cercopithecus aethiops Simplexvirus Viruses Influenza A Virus, H1N1 Subtype Influenza B virus Influenza A virus Orthomyxoviridae Hepatitis B virus HIV Herpesvirus 1, Human Herpesviridae Herpesvirus 2, Human Enterovirus A, Human Influenza A Virus, H3N2 Subtype Influenza A Virus, H5N1 Subtype Herpesvirus 3, Human Vesicular stomatitis Indiana virus Vaccinia virus Dogs Mice, Inbred BALB C Encephalomyocarditis virus SARS Virus Cricetinae Sendai virus Vesiculovirus Lymphocytic choriomeningitis virus Capsid RNA Viruses Mice, Inbred C57BL Mengovirus Rhinovirus Muromegalovirus Enterovirus B, Human Sindbis Virus Mice, Knockout Arenavirus Filoviridae Macaca mulatta Alphavirus Dengue Virus Newcastle disease virus Ectromelia virus Virion Respiratory Syncytial Viruses Thogotovirus

Diseases23

Influenza, Human Virus Diseases Herpes Simplex Cytomegalovirus Infections Hepatitis B, Chronic Hepatitis C, Chronic Hepatitis C Eye Infections, Viral Hepatitis B Herpes Zoster Herpesviridae Infections Orthomyxoviridae Infections HIV Infections Disease Models, Animal Recurrence RNA Virus Infections Vesicular Stomatitis Lymphocytic Choriomeningitis Rhabdoviridae Infections Arenaviridae Infections Vaccinia Viremia Alphavirus Infections

Chemicals and Drugs87

Antiviral Agents Acyclovir Organophosphonates Rimantadine Amantadine Trifluridine Oseltamivir Interferons Nucleosides Ribavirin Zanamivir Ganciclovir Cytosine Foscarnet Interferon-alpha Prodrugs Idoxuridine RNA, Viral Organophosphorus Compounds Zalcitabine Ribonucleosides Anti-HIV Agents Adenine 2-Aminopurine Zidovudine Lamivudine Reverse Transcriptase Inhibitors Pyrans Viral Proteins Viral Nonstructural Proteins Vidarabine Phosphate Interferon Type I Arabinonucleotides DNA, Viral Arabinofuranosyluracil Vidarabine Neuraminidase Interferon-beta Isoxazoles Dideoxynucleosides Myxovirus Resistance Proteins Influenza Vaccines Protease Inhibitors Guanine Polyethylene Glycols RNA Replicase Recombinant Proteins Guanidines Acetamides HIV Protease Inhibitors Ribosome Inactivating Proteins, Type 1 2',5'-Oligoadenylate Synthetase HIV Protease Valine Interferon Regulatory Factor-3 Thymidine Kinase DEAD-box RNA Helicases HIV Reverse Transcriptase Amides Enzyme Inhibitors RNA, Double-Stranded Thymidine DNA-Directed DNA Polymerase Peptides Oligopeptides Poly I-C Viral Envelope Proteins Recombinant Fusion Proteins Antibodies, Viral Interferon Inducers eIF-2 Kinase Receptors, Interferon Interferon-gamma Antineoplastic Agents STAT2 Transcription Factor Receptor, Interferon alpha-beta Cytidine Deaminase N-Glycosyl Hydrolases Toll-Like Receptor 3 STAT1 Transcription Factor Antigens, Viral Interferon Regulatory Factor-7 vif Gene Products, Human Immunodeficiency Virus RNA, Small Interfering Cytokines Interferon-Stimulated Gene Factor 3, gamma Subunit RNA Helicases

Analytical, Diagnostic and Therapeutic Techniques and Equipment29

Viral Plaque Assay Inhibitory Concentration 50 Drug Therapy, Combination Treatment Outcome Drug Evaluation, Preclinical Viral Load Cytopathogenic Effect, Viral Drug Design Models, Molecular Microbial Sensitivity Tests Administration, Oral Administration, Topical Disease Models, Animal Risk Factors Models, Biological Clinical Trials as Topic Liver Transplantation Retrospective Studies Polymerase Chain Reaction Prospective Studies Magnetic Resonance Spectroscopy Transfection Chromatography, High Pressure Liquid Follow-Up Studies Drug Administration Schedule Severity of Illness Index Cohort Studies Double-Blind Method Analysis of Variance

Psychiatry and Psychology1

Phenomena and Processes40

Virus Replication Drug Resistance, Viral Time Factors Inhibitory Concentration 50 Virus Internalization Viral Load Cytopathogenic Effect, Viral Structure-Activity Relationship Dose-Response Relationship, Drug Replicon Amino Acid Sequence Virus Activation Molecular Structure Mutation Immunity, Innate Virus Assembly Genotype Base Sequence Immunocompromised Host Kinetics Drug Resistance, Microbial Protein Binding RNA, Double-Stranded Host-Pathogen Interactions Cell Survival Drug Synergism Binding Sites Pregnancy Transfection RNA Interference Protein Conformation Virus Physiological Phenomena Signal Transduction Action Potentials Substrate Specificity Sleep Gene Expression Regulation, Viral Gene Expression Regulation Viral Interference Immune Evasion

Disciplines and Occupations1

Technology, Industry, Agriculture1

Polyethylene Glycols

Information Science3

Molecular Sequence Data Amino Acid Sequence Base Sequence

Health Care14

Post-Exposure Prophylaxis Treatment Outcome Disease Outbreaks Risk Factors Clinical Trials as Topic Retrospective Studies Prospective Studies Follow-Up Studies Severity of Illness Index Cohort Studies Pandemics Age Factors Double-Blind Method Analysis of Variance

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care Geographicals

Antiviral Agents Virus Replication Acyclovir Organophosphonates Rimantadine Drug Resistance, Viral Amantadine Trifluridine Oseltamivir Viral Plaque Assay Influenza, Human Interferons Nucleosides Ribavirin Zanamivir Ganciclovir Hepacivirus Cell Line Cytosine Virus Diseases Vero Cells Foscarnet Interferon-alpha Prodrugs HIV-1 Time Factors Idoxuridine Cytomegalovirus Cercopithecus aethiops RNA, Viral Organophosphorus Compounds Zalcitabine Simplexvirus Ribonucleosides Viruses Anti-HIV Agents Adenine Influenza A Virus, H1N1 Subtype Influenza B virus 2-Aminopurine Influenza A virus Post-Exposure Prophylaxis Orthomyxoviridae Hepatitis B virus Herpes Simplex Zidovudine Lamivudine Reverse Transcriptase Inhibitors Pyrans Viral Proteins Cytomegalovirus Infections Inhibitory Concentration 50 Hepatitis B, Chronic Hepatitis C, Chronic Viral Nonstructural Proteins Drug Therapy, Combination HIV Treatment Outcome Herpesvirus 1, Human Vidarabine Phosphate Molecular Sequence Data Interferon Type I Arabinonucleotides DNA, Viral Arabinofuranosyluracil Drug Evaluation, Preclinical Virus Internalization Cells, Cultured Vidarabine Viral Load Hepatitis C Cytopathogenic Effect, Viral Herpesviridae Herpesvirus 2, Human Neuraminidase Structure-Activity Relationship Drug Design Enterovirus A, Human Eye Infections, Viral Interferon-beta Hepatitis B Isoxazoles Herpes Zoster Dideoxynucleosides Dose-Response Relationship, Drug Influenza A Virus, H3N2 Subtype Myxovirus Resistance Proteins Influenza A Virus, H5N1 Subtype Influenza Vaccines Replicon Protease Inhibitors Guanine Amino Acid Sequence Virus Activation Herpesvirus 3, Human Vesicular stomatitis Indiana virus Vaccinia virus Herpesviridae Infections Polyethylene Glycols Disease Outbreaks

No FAQ available that match "duration antiviral agents"